Back to eLearning

eLearning

4.03 | PRESCRIBER AND DISPENSER TRAINING - QScript - High-risk clinical scenarios

eLEARNING SERIESPRESCRIBER AND DISPENSER TRAINING
MODULE NAMEQScript - High-risk clinical scenarios
MODULE NUMBERModule 10 of 11
LEARNING LEVELLevel 4 – AOD Treatment Specific
TARGET AUDIENCEHealth practitioners who are able to prescribe or dispense monitored medicines and access QScript.
MODULE AIM

Completion of this module will enable prescribers and pharmacists to understand the clinical application of QScript’s high-risk clinical scenarios and the related notification function. This module will discuss each high-risk clinical scenario where a patient may be at risk of serious harms associated with the use of monitored medicines.

Under the Medicines and Poisons Act 2019 relevant practitioners (medical practitioners, pharmacists and intern pharmacists, nurse practitioners, endorsed midwives, dentists, podiatric surgeons and endorsed podiatrists) are required to check QScript before prescribing, dispensing or giving a treatment dose of a monitored medicine for a patient (unless an exemption applies under Schedule 18, Part 1A of the Medicines and Poisons (Medicines) Regulation 2021). Separately, all prescribers and dispensers providing monitored medicine treatment to a patient currently registered on the Queensland Opioid Treatment Program (QOTP) must comply with the minimum requirements stipulated in the Monitored Medicines Standard, if prescribing a monitored medicine for dispensing or for giving a treatment dose, or if dispensing a monitored medicine for the patient. 

LEARNING OUTCOMES

By the end of this module, learners will be able to:

  • A – patient is currently registered on the Queensland Opioid Treatment Program (QOTP)
  • B - patient was previously registered on the Queensland Opioid Treatment Program (QOTP)
  • C - patient receiving monitored medicines from multiple prescribers
  • D - increased patient overdose risk— average total daily opioids of 100mg oral morphine equivalent (OME) or greater
  • E - increased patient overdose risk—opioid and benzodiazepine / z-drug (zopiclone and zolpidem) combination
  • F - patient receiving an opioid or benzodiazepine / z-drug for the first time in 90 days
LENGTH2 hours
CPDParticipation in this activity may contribute to CPD. A Statement of Completion will be issued on completion of this module. 
REFERENCE LISTAvailable here
SUGGESTED CITATIONInsight: Centre for AOD Training and Workforce Development. Prescriber and dispenser training: QScript - High-risk clinical scenarios. Brisbane: Queensland Health; 2025. Available from: https://insight.qld.edu.au/training/elearning
COPYRIGHT INFORMATIONThis resource is licensed under Attribution-NoDerivatives 4.0 International (CC BY-ND 4.0). This license requires that reusers give credit to the creator. It allows reusers to copy and distribute the material in any medium or format in unadapted form only, even for commercial purposes.
ACKNOWLEDGEMENTSQScript Learning was funded by the Prevention Division within the Queensland State Government’s Department of Health.  
LAST UPDATEDJune 2023
REVIEW AND FEEDBACKAs part of our commitment to continuous quality improvement our eLearning modules undergo a minor review every 2 years, and a major review every 4 years. All evaluation responses are carefully considered during these reviews.  If you have significant or urgent feedback, we encourage you to email us directly at insight@health.qld.gov.au